Joseph Dunham has served as CEO and President of OneroRx since July of 2019 and has been chairman of the Board of Directors since 2021. Prior to joining the company, he served in multiple executive leadership positions at several private and public healthcare companies, including working with legendary healthcare investor John Pappajohn. During his tenure as CEO at OneroRx, he has overseen a rapid expansion of business and was honored as an Ernst & Young Entrepreneur of the Year Heartland Award winner for 2024.

Prior to OneroRx, Joseph was Senior Vice President of Eurofins Scientific, Inc., an international laboratory testing company where he was named Business Leader of the Year in 2015. He has over 30 years of healthcare experience and has overseen over $1 billion of mergers and acquisitions and advisory transactions in the healthcare industry. He has a reputation for building management teams and growing companies. He also serves as an Advisory Board Member of Harvard Medical Technology, an e-healthcare technology company. He received his BA from Wartburg College and his MBA from Drake University.